Knocking down of ABL2 in breast cancer cells (using a mouse xenograft model) leads to increased tumor cell proliferation and a significantly enlarged tumor size in breast cancer (Gil-Henn et al., 2013). Here, ABL2 is linked to breast carcinoma.